Requests similar to 'Meeting notes and outcomes' (page 2)
Immunosuppressed/diabetic/cancer populations - common associated conditions.
Response by Pharmaceutical Management Agency to J Bruning on .
Information not held.
Kia ora Jodie,
Please find attached a response to your Official Information Act request of 17 April 2024.
Thank you
Government Services
_____________...
Trikafta "27 more years at full health" claim.
Response by Pharmaceutical Management Agency to Laydan Mortensen on .
Successful.
Kia ora Laydan
Thank you for your request for official information, which Pharmac received on 17 January 2025. The reference number for your request i...
Kia ora Simon
Thank you for your request for information, received by Pharmac on 5 February 2024. Your request has been received and logged. Our refer...
Kia ora Simon
Thank you for your request for information, received by Pharmac on 1 April 2024. Your request has been received and logged. Our referenc...
MoH criteria for Special Authority application of stimulant medication
Response by Pharmaceutical Management Agency to Cody C on .
Information not held.
Kia ora Cody C
Thank you for your request for information, received by Pharmac on 30 November 2023. Your request has been received and logged. Our ref...
Meeting with New Minister for Pharmac
Response by Pharmaceutical Management Agency to T Murray on .
Refused.
Kia ora T Murray
Thank you for your request for information, received by Pharmac on 1 December 2023. Your request has been received and logged. Our re...
Kia ora T Murray
Thank you for your request for information, received by Pharmac on 21 December 2023. Your request has been received and logged. Our r...
Shortage of prescribed medication Concerta
Response by Pharmaceutical Management Agency to gerald on .
Awaiting classification.
Kia ora Gerald
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
__...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Request sent to Pharmaceutical Management Agency by J Bruning on .
Successful.
Please provide me with the following information that is held by Pharmac, that Pharmacology and Therapeutics Advisory Committee (PTAC) or the COVID-...
Conflicts of interest at NZ Immunisation Advisory Service
Response by Ministry of Health to Erika Whittome on .
Refused.
Kia ora Erika
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
___...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J
Thank you for your request for official information, which Pharmac received on . The reference number for your request is: 2025-26-042
You...
Procurement process for Cormack Draper
Response by Pharmaceutical Management Agency to Harris Leigh on .
Partially successful.
Tçnâ koe Harris
Please find a response to your below request for information attached to
this email.
Ngâ mihi, nâ
Melody Willis...
Recent expenditure on Chemotherapy, Anticoagulants and Immunomodulaters
Response by Pharmaceutical Management Agency to Matthew Shelton on .
Successful.
Kia ora Matthew
Please accept our sincere apologies for missing some of the data in your
previous response
Please find attached the updated da...
Please supply the Pfizer Comirnaty BNT162b2 contract with the NZ Government
Response by Pharmaceutical Management Agency to John Armstrong on .
Refused.
Kia ora John
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
____...
Tçnâ koe
Please find a response to your request for information attached.
Ngâ mihi, nâ
Melody Willis (she/her) | Government Services Advisor
______...
Under 40s - extent of co-prescribing for ADHD, anxiety, depression.
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora Jodie,
Please find attached a response to your Official Information Act request,
which was received on 2 October 2024.
Please cont...
Cancer drugs v other drugs
Response by Pharmaceutical Management Agency to Brendon Mills on .
Successful.
Kia ora Brendon
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
_...
Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003
Response by Pharmaceutical Management Agency to Harris Leigh on .
Successful.
Tçnâ koe Harris
Thank you for your email.
May I please confirm regarding point 1 of your request, does this relate
to communications with...
Kia ora,
Please see attached your response.
Arihia Gray [1](she/her) | Policy advisor
From:
Sent:
To:
Cc:
Subject:
Sarah Fitt
Friday,...
List of Controlled Documents
Response by Waikato District Health Board to Amy S Van Wey Lovatt (Account suspended) on .
Partially successful.
Good morning Amy
Please find attached the response to your information requests, including
the requested documents.
Regards
Christin...
Comirnaty (JN.1) vaccine
Response by Pharmaceutical Management Agency to Catherine Jamieson on .
Successful.
Kia ora Catherine
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Official Information Act Request – Provisions of Pfizer Vaccine Procurement Agreements
Response by Ministry of Business, Innovation & Employment to John Armstrong on .
Refused.
Kia ora John
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
ADHD and Maori/Pacific
Response by Pharmaceutical Management Agency to Rodney Parsons on .
Successful.
Hi Rodney,
Thank you for email and confirming the scope.
You should receive a response from us on or before 20 November 2024. This is within the 20 w...
Total number of traffic incidents and accidents involving Diabetic drivers using insulin in last 5 years
Request sent to New Zealand Transport Agency by Christoper Walls on .
Partially successful.
I am requesting the following information relating to the years from 1 January 2009 until and including 31 December 2014
1 The total number of t...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find attached a response to your request for information about
remdesivir.
Ngā mihi
Melody Willis ([1]she/h...